Video
Author(s):
How can new formulations of ketamine impact patient care?
Jeffrey Becker, MD, discusses new formulations of ketamine for subcutaneous delivery and how ketamine works.
Dr Becker is cofounder and Chief Scientific Officer at Bexson Biomedical, Inc.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.